FBXW7 and cancer: Nonetheless, the in vivo combined with in vitro studies on miRNA upstream regulators are relatively rare, the mechanisms of miRNAs targeting FBXW7 to confer therapeutic resistance of cancers remain elusive, and the effective delivery of miRNA mimics or anti-miRNAs to realize significant clinical values is awaiting to be elucidated.